Revised SPC: ethinylestradiol/gestodene (Femodette, Femodene) and cyproterone acetate/ethinylestradiol (Dianette) tablets

SPCs have been updated to include wording on a potential drug-drug interaction of ethinylestradiol containing products with Maviret (glecaprevir/pibrentasvir) leading to risk of ALT elevations. Concomitant use is contraindicated.

electronic Medicines compendium